Graft Versus Host Disease (GvHD) Latest Advances

A Study of Epidermal Elafin Immunohistochemistry as a Diagnostic Biomarker of Acute Skin GVHD.

Journal: Indian journal of dermatology

Published: September 08, 2026

The causes of death in elderly patients undergoing haploidentical stem cell transplantation

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Impact of recipient age on outcomes of allogeneic hematopoietic stem cell transplantation: an analysis from the Chinese Bone Marrow Transplant Registry Group (CBMTRG)

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Research advances in mesenchymal stem cell therapy for graft-versus-host disease

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Shared Care After Pediatric Nonmalignant Hematopoietic Cell Transplantation.

Journal: Pediatric annals

Published: September 03, 2026

Comment on "Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time".

Journal: Transplantation and cellular therapy

Published: September 02, 2026

The Immunology of Transfusion Medicine: Past, Present, and Future.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 02, 2026

Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation.

Journal: Current opinion in hematology

Published: August 31, 2026

Second-line and salvage therapies for steroid-refractory acute graft-versus-host disease: an integrated synthesis of current evidence and clinical sequencing.

Journal: Current opinion in hematology

Published: August 31, 2026

Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 30, 2026

Fusarium solani Skin and Soft Tissue Infection in a Patient With Chronic Sclerosing Skin Graft-vs-Host Disease: A Case Report.

Journal: The American journal of case reports

Published: August 28, 2026

Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.

Journal: Journal of translational internal medicine

Published: August 27, 2026

Graft Versus Host Disease (GvHD) Latest Advances

Find the Latest Research About Graft Versus Host Disease (GvHD)

A Study of Epidermal Elafin Immunohistochemistry as a Diagnostic Biomarker of Acute Skin GVHD.

A Study of Epidermal Elafin Immunohistochemistry as a Diagnostic Biomarker of Acute Skin GVHD.

The causes of death in elderly patients undergoing haploidentical stem cell transplantation

The causes of death in elderly patients undergoing haploidentical stem cell transplantation

Impact of recipient age on outcomes of allogeneic hematopoietic stem cell transplantation: an analysis from the Chinese Bone Marrow Transplant Registry Group (CBMTRG)

Impact of recipient age on outcomes of allogeneic hematopoietic stem cell transplantation: an analysis from the Chinese Bone Marrow Transplant Registry Group (CBMTRG)

Research advances in mesenchymal stem cell therapy for graft-versus-host disease

Research advances in mesenchymal stem cell therapy for graft-versus-host disease

Shared Care After Pediatric Nonmalignant Hematopoietic Cell Transplantation.

Shared Care After Pediatric Nonmalignant Hematopoietic Cell Transplantation.

Comment on "Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time".

Comment on "Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time".

The Immunology of Transfusion Medicine: Past, Present, and Future.

The Immunology of Transfusion Medicine: Past, Present, and Future.

Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation.

Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation.

Second-line and salvage therapies for steroid-refractory acute graft-versus-host disease: an integrated synthesis of current evidence and clinical sequencing.

Second-line and salvage therapies for steroid-refractory acute graft-versus-host disease: an integrated synthesis of current evidence and clinical sequencing.

Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm

Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm

Fusarium solani Skin and Soft Tissue Infection in a Patient With Chronic Sclerosing Skin Graft-vs-Host Disease: A Case Report.

Fusarium solani Skin and Soft Tissue Infection in a Patient With Chronic Sclerosing Skin Graft-vs-Host Disease: A Case Report.

Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.

Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.